Resonant Clinical Solutions Expands Advanced-Therapy and Cryogenic Storage Capabilities with Acquisition of Creapharm Bioservices

Positive

AI Analysis

Summary

Resonant Clinical Solutions acquired Creapharm Bioservices to expand its advanced-therapy and cryogenic storage capabilities in Europe, strengthening its global biorepository offering for complex clinical programs including cell and gene therapies.

Importance:6/10

Sentiment:

0.60

M&Aacquisitionbiorepositoryadvanced therapycryogenic storagecell therapygene therapyclinical servicesEurope

Related Companies

$GBCYD

Read the original article

Published by PR Newswire Biotech on September 3, 2026 1:29 PM

Read Original